Medicenna Therapeutics Corp
TSX:MDNA
Medicenna Therapeutics Corp
TSX:MDNA
Price:
0.84
CAD
Market Closed
Market Cap:
CA$65.7m
Balance Sheet
Balance Sheet Decomposition
Medicenna Therapeutics Corp
Medicenna Therapeutics Corp
Balance Sheet Decomposition is not available for
Medicenna Therapeutics Corp
Medicenna Therapeutics Corp
Balance Sheet
Medicenna Therapeutics Corp
Medicenna Therapeutics Corp
Currency: CAD
| Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
14
|
4
|
2
|
23
|
30
|
21
|
34
|
17
|
25
|
|
| Cash Equivalents |
14
|
4
|
2
|
23
|
30
|
21
|
34
|
17
|
25
|
|
| Short-Term Investments |
0
|
0
|
0
|
15
|
10
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
2
|
0
|
0
|
1
|
1
|
1
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
|
| Total Current Assets |
14
|
4
|
5
|
38
|
42
|
23
|
36
|
19
|
28
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
14
N/A
|
4
-70%
|
5
+19%
|
38
+632%
|
42
+11%
|
23
-44%
|
36
+55%
|
19
-48%
|
28
+48%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
2
|
1
|
0
|
2
|
2
|
2
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
7
|
2
|
2
|
2
|
4
|
3
|
4
|
3
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
11
|
5
|
|
| Total Liabilities |
8
N/A
|
2
-72%
|
3
+16%
|
2
-28%
|
4
+122%
|
3
-36%
|
7
+166%
|
14
+100%
|
9
-33%
|
|
| Equity | ||||||||||
| Common Stock |
13
|
14
|
17
|
57
|
80
|
84
|
101
|
101
|
116
|
|
| Retained Earnings |
11
|
18
|
23
|
31
|
48
|
71
|
81
|
106
|
118
|
|
| Additional Paid In Capital |
4
|
6
|
9
|
10
|
7
|
8
|
9
|
11
|
21
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
2
-68%
|
3
+21%
|
36
+1 280%
|
38
+6%
|
21
-45%
|
29
+42%
|
5
-82%
|
19
+268%
|
|
| Total Liabilities & Equity |
14
N/A
|
4
-70%
|
5
+19%
|
38
+632%
|
42
+11%
|
23
-44%
|
36
+55%
|
19
-48%
|
28
+48%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
24
|
25
|
29
|
47
|
54
|
56
|
70
|
70
|
78
|
|
Switch to:
Switch to:
See Also
Discover More
